A prospective randomized trial of two fractionation regimens of radiation therapy in the management of AIDS- associated Kaposi Sarcoma

Simple item page
dc.contributor.authorSingh, Niveditha Bhavna
dc.date.accessioned2007-02-14T13:11:33Z
dc.date.available2007-02-14T13:11:33Z
dc.date.issued2007-02-14T13:11:33Z
dc.descriptionStudent Number : 9201769X - M Med research report - School of Clinical Medicine - Faculty of Health Sciencesen
dc.description.abstractA PROSPECTIVE RANDOMIZED TRIAL OF TWO FRACTIONATION REGIMENS OF RADIATION THERAPY IN THE MANAGEMENT OF AIDSASSOCIATED KAPOSI SARCOMA OBJECTIVE: To compare a standard fractionation scheme with a hypofractionated scheme in the treatment of AIDS-associated Kaposi sarcoma with the aim of showing noninferiority of the shorter schedule. PATIENTS AND METHODS: HIV positive patients with histologically proven Kaposi sarcoma presenting consecutively to Radiation Oncology at Johannesburg Hospital were randomized between January 2003 and May 2004 to receive a standard regimen of 24 Gy in 12 fractions (ARM A) or the study regimen of 20 Gy in 5 fractions (ARM B). The radiation technique used was individualized for each site in accordance with departmental practice. Follow-up assessment was done at monthly intervals. Treatment response and toxicity were recorded at each follow-up visit. RESULTS: A total of 60 patients were recruited, of which 41 were male and 19 were female. The median age was 36 years (range: 23 – 55 years). Thirteen patients died prior to receiving treatment. The remaining 47 patients were treated to 65 sites, of which 35 sites received 24 Gy in 12 fractions (ARM A) and 30 sites received 20 Gy in 5 fractions (ARM B). The main indications for treatment were pain (n=71), oedema (n=44), functional impairment (n=35), cosmesis (n=14) and bleeding (n=4). At the time of reporting 28 patients were alive and 32 patients have died. The overall survival of the whole group was 37% at 1 year. A complete response was recorded at 28 sites, a partial response at 19 sites and stable disease at 3 sites. The mean time to maximum objective response was 3 months (range: 1 – 14 months). The response rates were equal in the 2 treatment arms (p=0.73). Local control was equal in the 2 treatment arms with a median local recurrence free survival of 150 days for ARM A and 455 days for ARM B (p=0.11, log rank test). Acute skin toxicity occurred at 27 sites. Moist desquamation developed at 7 sites while necrosis developed at 2 sites. Acute skin toxicity was equal in the 2 treatment arms (p=0.77). Acute mucosal toxicity occurred at 2 sites. Late skin reactions developed at 21 sites, of which necrosis or ulceration occurred at 5 sites. Chronic skin reactions were equivalent in the 2 treatment arms (p=0.24). Post radiation oedema developed at 5 sites. CONCLUSION: In our experience, 20 Gy in 5 fractions gave similar results to 24 Gy in 12 fractions in terms of treatment response, local recurrence free survival and toxicity in this small group of patients.en
dc.format.extent10996 bytes
dc.format.extent10827 bytes
dc.format.extent39906 bytes
dc.format.extent22639 bytes
dc.format.extent10642 bytes
dc.format.extent21764 bytes
dc.format.extent50489 bytes
dc.format.extent11985 bytes
dc.format.extent24283 bytes
dc.format.extent21538 bytes
dc.format.extent11866 bytes
dc.format.extent65786 bytes
dc.format.extent3829849 bytes
dc.format.extent10330 bytes
dc.format.extent12312 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.identifier.urihttp://hdl.handle.net/10539/1991
dc.language.isoenen
dc.subjectkaposi sarcomaen
dc.subjectradiation therapyen
dc.subjectAIDSen
dc.subjectPalliative treatmenten
dc.subjectFractionation Regimensen
dc.titleA prospective randomized trial of two fractionation regimens of radiation therapy in the management of AIDS- associated Kaposi Sarcomaen
dc.typeThesisen
Files
Original bundle
Now showing 1 - 5 of 15
No Thumbnail Available
Name:
SinghNB_ABSTRACT.pdf
Size:
12.02 KB
Format:
Adobe Portable Document Format
Description:
Download
No Thumbnail Available
Name:
SinghNB_AIMS AND OBJECTIVES.pdf
Size:
10.09 KB
Format:
Adobe Portable Document Format
Description:
Download
No Thumbnail Available
Name:
SinghNB_Appendices.pdf
Size:
3.65 MB
Format:
Adobe Portable Document Format
Description:
Download
No Thumbnail Available
Name:
SinghNB_CLEARANCE CERTIFICATES.pdf
Size:
64.24 KB
Format:
Adobe Portable Document Format
Description:
Download
No Thumbnail Available
Name:
SinghNB_CONCLUSION.pdf
Size:
11.59 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
87 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
ETD Collection